Anuja Mitra

Dr. Anuja Mitra

Imperial College London, London, City of London, UK
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2022 in Metabolites
Verified
Journal Article
Open access
PDF file
AMAnuja Mitra
Anuja Mitra
SCSunyoung Choi
Sunyoung Choi
PBPiers R. Boshier
Piers R. Boshier
ARAlexandra Razumovskaya-Hough
Alexandra Razumovskaya-Hough
Ilaria BelluomoIlaria Belluomo
Ilaria Belluomo
GHGeorge B. Hanna
George B. Hanna
The analysis of volatile organic compounds (VOCs) can provide important clinical information (entirely non-invasively); however, the exact extent to which VOCs from human skin can be signatures of health and disease is unknown. This systematic review summarises the published literature concerning the methodology, application, and volatile profiles of skin VOC studies. An online literature search was conducted in accordance with the preferred reporting items for systematic reviews and meta-analysis, to identify human skin VOC studies using untargeted mass spectrometry (MS) methods. The principal outcome was chemically verified VOCs detected from the skin. Each VOC was cross-referenced using the CAS number against the Human Metabolome and KEGG databases to evaluate biological origins. A total of 29 studies identified 822 skin VOCs from 935 participants. Skin VOCs were commonly sampled from the hand (n = 9) or forearm (n = 7) using an absorbent patch (n = 15) with analysis by gas chromatography MS (n = 23). Twenty-two studies profiled the skin VOCs of healthy subjects, demonstrating a volatolome consisting of aldehydes (18%), carboxylic acids (12%), alkanes (12%), fatty alcohols (9%), ketones (7%), benzenes and derivatives (6%), alkenes (2%), and menthane monoterpenoids (2%). Of the VOCs identified, 13% had putative endogenous origins, 46% had tentative exogenous origins, and 40% were metabolites from mixed metabolic pathways. This review has comprehensively profiled the human skin volatolome, demonstrating the presence of a distinct VOC signature of healthy skin, which can be used as a reference for future researchers seeking to unlock the clinical potential of skin volatolomics. As significant proportions of identified VOCs have putative exogenous origins, strategies to minimise their presence through methodological refinements and identifying confounding compounds are discussed.

15 October 2025 in Obesity Surgery
Verified
Journal Article
Open access
PDF file
AMAnuja Mitra
Anuja Mitra
ABAmit Bhambri
Amit Bhambri
MFMatyas Fehervari
Matyas Fehervari
CPChetan Parmar
Chetan Parmar
Background: One-anastomosis gastric bypass (OAGB) has gained global prominence as the third most performed bariatric procedure. Despite evidence of short-term efficacy, long-term outcomes remain understudied. Methods: This PRISMA-compliant systematic review and meta-analysis evaluated long-term (≥ 5 years) outcomes of OAGB as primary and revisional procedures. Quality assessment and bias evaluation were conducted systematically. Results: Analysis included 32 studies with 19,125 patients (76% primary OAGB) from 14 countries with mean follow-up of 6.7 years. At five years, mean excess weight loss(EWL) was 75%, increasing to 77% beyond five years. Obesity associated diseases resolution was substantial: type 2 diabetes (80%), obstructive sleep apnea (89%), and hypertension (61%). Complications were minimal: bile reflux (4%), marginal ulceration (2%), and malnutrition (1%). For revisional OAGB, %EWL at five years was 71%. The conversion rate to other bariatric procedures (all RYGB) was reported in 3% of patients following OAGB. Conclusion: This analysis demonstrates OAGB's effectiveness for sustained weight loss and obesity associated diseases improvement at ≥ 5 years, supporting its role in long-term obesity management as a primary and revisional bariatric intervention.

2 February 2024 in eClinicalMedicine
Verified
Journal Article
Open access
AMAnuja Mitra
Anuja Mitra
BDBibek Das
Bibek Das
KSKhalid Maher Sarraf
Khalid Maher Sarraf
MFMartha Ford-Adams
Martha Ford-Adams
MFMatyas Fehervari
Matyas Fehervari
HAHutan Ashrafian
Hutan Ashrafian
Childhood obesity is a pressing health crisis of epidemic proportions. Bariatric surgery (BS) is an effective weight loss solution however its role in the paediatric population is contentious owing to the paucity of weight specific and generalised health outcomes. This systematic review and meta-analysis aimed to assess the impact of paediatric BS on bone health. This prospectively registered systematic review (PROSPERO ID: CRD42023432035) was performed in accordance with PRISMA guidelines. We searched MEDLINE (1946–1928 September 2023), EMBASE (1947–1928 September 2023) via the Ovid platform, and the Cochrane Review Library to identify scientific publications reporting bone outcome measures in patients under the age of 18 years who underwent BS. Meta-analysis was undertaken on post-operative weight and bone parameters in paediatric patients following BS. Outcomes were reported as weighted or standardized mean difference with 95 percent confidence intervals. Subgroup analysis by intervention, quality scoring and risk of bias were assessed. Twelve studies with 681 patients across 5 countries (mean age 17 ± 0.57 years) were included. The quality of included studies was rated as high and there was substantial between-study heterogeneity for most factors included in the meta-analysis (I2 from 0% to 99.1%). Patients underwent Roux-en-Y gastric bypass (RYGB, n = 216), sleeve gastrectomy (SG, n = 257), gastric band (n = 184) or intragastric balloon placement (n = 24). BS was associated with significant weight reduction, body mass index (BMI) −12.7 kg/m2 (95% CI −14.5 to −10.9, p < 0.001), with RYGB being most effective, BMI −16.58 kg/m2 (95% CI −19.6 to −13.6, p < 0.001). Patients who underwent SG or RYGB had significantly lower lumbar bone mineral density, −0.96 g/cm2 (95% CI −0.1 to −0.03, p < 0.001), Z score, −1.132 (95% CI −1.8 to −0.45, p < 0.001) and subtotal body bone mineral density, −0.7 g/cm2 (95% CI −1.2 to −0.2, p < 0.001) following surgery. This was accompanied with higher markers of bone resorption, C-terminal telopeptide of type 1 collagen 0.22 ng/ml (95% CI 0.12–0.32, p < 0.001) and osteocalcin, 10.83 ng/ml (95% CI 6.01–15.67, p < 0.001). There was a significant reduction in calcium levels following BS, −3.78 mg/dl (95% CI −6.1 to −1.5, p < 0.001) but no difference in 25-hydroxyvitamin D, phosphate, bone alkaline phosphatase, procollagen type 1 N propeptide or parathyroid hormone. BS effectively reduces weight in paediatric patients, but RYGB and SG may have adverse effects on bone health in the medium term. It is crucial to monitor and support bone health through appropriate nutritional supplementation and judicious follow-up. Long-term data is needed to fully understand the clinical implications of these findings on bone outcomes. 10.13039/501100000265 Medical Research Council (MRC), United Kingdom.

16 October 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
AMAnuja Mitra
Anuja Mitra
OWOlivia Wing
Olivia Wing
BDBibek Das
Bibek Das
NGNaim Fakih- Gomez
Naim Fakih- Gomez
HKHaris Khwaja
Haris Khwaja
MFMatyas Fehervari
Matyas Fehervari
Metabolic bariatric surgery (MBS) is an effective treatment for paediatric obesity, yet the mechanisms underlying weight loss remain unclear. This systematic review and meta-analysis evaluated the short- and long-term effects of MBS on the paediatric metabolome to provide insights into metabolic pathways contributing to surgical outcomes. This prospectively registered systematic review (PROSPERO ID: CRD42024607784) adhered to PRISMA guidelines. Meta-analysis was undertaken on pre-defined post-operative weight and metabolic parameters in paediatric patients (aged 5- 19 years) following MBS. Outcomes were reported as weighted or standardised mean Difference with 95 percent confidence intervals from random effects modelling. Quality scoring and quantitative assessment of bias were performed. Results from 12 studies (451 patients, mean age 16.9 years) across five countries were included. The median follow-up was 12 months. Patients underwent Roux-en-Y gastric bypass (RYGB, n = 275) or laparoscopic sleeve gastrectomy (LSG, n = 140). Most studies used serum and urine assays; two included tissue biosamples. MBS was associated with significant long-term weight reduction, with a mean BMI decrease of -14.4 kg/m2 (95% CI: -17.5 to -11.3) and %TWL of 25% (95% CI: 18.6 to 32.2). Metabolic improvements included reduced cholesterol (-10 mg/dL), LDL (-14.6 mg/dL), triglycerides (-33.3 mg/dL), and increased HDL (+ 8.0 mg/dL). Significant enhancements were noted in glycaemic, pancreatic and insulin regulation, evidenced by decreased HOMA-IR (-4.1) and C-peptide (-1.8 ng/mL). Liver function parameters, ALT (-14.4 U/L), AST (-5.4 U/L), and GGT (-9.6 U/L) and inflammatory cytokines, IL-6 (-12.2 pg/mL) and TNF-α (-54 pg/mL) significantly declined following surgery. These findings demonstrate a distinct metabolic signature of MBS in adolescents, leading to substantial weight loss and improvements in cardiovascular, glycaemic, and liver health, alongside reduced systemic inflammation. These results underscore the efficacy of MBS as a therapeutic intervention for adolescents living with severe obesity, demonstrating a profound impact on the paediatric metabolome.

18 July 2023 in JMIR Preprints
Verified
Preprint
Open access
AMAnuja Mitra
Anuja Mitra
SMSheraz Markar
Sheraz Markar
FNFelix Nickel
Felix Nickel
ACAmila Cizmic
Amila Cizmic
BACKGROUND Minimally invasive total gastrectomy (MITG) has demonstrated superiority over open surgery for general surgical outcomes and oncological equivalence in patients with gastric cancer. MITG is an advanced laparoscopic operation requiring a high level of technical skill. For oncological indications, key principles of lymphadenectomy of nodal stations and achieving an R0 resection margin must be respected. To standardize clinical outcomes and maintain surgical quality of MITG, there must be a consensus on the key technical steps and surgical technique of the lymphadenectomy and anastomosis creation which are currently lacking. OBJECTIVE The aim of this study is to determine an expert consensus from an international panel regarding the technical performance of MITG using a Delphi method. METHODS A novel scoping questionnaire will be created based on the deconstruction of MITG into its integral technical steps through local and international expert opinion and literature evidence. Expert surgeons in minimally invasive upper gastrointestinal surgery across the globe will be invited to participate in an online Delphi consensus. The panelists will vote on the issues generated in previous rounds concerning importance, difficulty, or agreement of statements grouped into 4 broad domains of the Delphi. A priori definition of consensus will be set at 80% agreement. Internal consistency and reliability will be evaluated using Cronbach's alpha, and univariate statistics will be undertaken on individual outcome measures. This process will repeat until consensus is reached on all statements and a final guidance can be reported. RESULTS The Delphi rounds will deliver necessary consensus statements regarding MITG lymphadenectomy and general aspects of anastomosis creation. CONCLUSIONS The results of this study will generate for the first-time, consensus statements regarding the optimal technical steps in performing MITG for oncological indications. It will inform best surgical practices and provide a platform for creating surgical video-assessment tools designed to improve clinical outcomes and standardize surgical quality in MITG. CLINICALTRIAL Not applicable